Company intelligence / Profile preview
Diamune Therapeutics
Beverly, Massachusetts, United Statesdiamune.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Diamune Therapeutics was spun out of Akston Biosciences in August 2023 to focus on developing innovative IgG Fc-Fusion insulin analogs designed to mitigate and prevent autoimmune diabetes. The company leverages the proprietary Ambifect™ Fc-fusion protein platform originally developed at Akston. While specific clinical results are not yet published, the company’s technology has been granted patents for ultra-long acting insulins and candidates aimed at delaying or preventing autoimmune diabetes. Manufacturing capabilities are supported by facilities inherited from Akston Biosciences.
- Therapeutic areas
- Endocrinology
- Modalities
- Protein therapeuticsFc-fusion proteinsInsulin analogs
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
No external partnerships disclosed for Diamune specifically as of May 2025; parent company has licensed related veterinary insulins to Dechra Pharmaceuticals PLC.
Beyond the preview
Go deeper on Diamune Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Diamune Therapeutics.